Ads
related to: pharmaceutical drug companies
Search results
Face filler expected to soar with cases of gaunt ‘Ozempic face’ — and one company is cashing in
New York Post· 11 hours agoA saggy, sunken face is a hallmark of Ozempic use, but one pharmaceutical company wants to fix that....
Mark Cuban has a simple question for CVS’s drug middleman: Why don’t you publish your prices?
Ohio Capital Journal via Yahoo News· 17 hours agoBusinessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug...
Analyst Report: West Pharmaceutical Services, Inc.
Morningstar Research via Yahoo Finance· 11 hours agoWest Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug ...
...Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs - Vertex ...
Benzinga· 8 hours agoVertex Pharmaceuticals Inc‘s VRTX blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some ...
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 6 hours agoThe pharmaceutical giant delivered first-quarter sales and earnings results that topped estimates....
...Establish Joint Venture Company for Incubation of Early Drug Discovery Programs...OTC:ALPMY),...
Benzinga· 5 days agoTakeda Pharmaceutical Company Limited TAK President and CEO, Christophe Weber, ", Takeda", ))), Astellas...signed a master agreement on April 22, 2024, ...
Doctors ‘bribed to use infected blood products’
The Telegraph via Yahoo News· 6 hours agoIn the 1970s and 1980s, 1,250 people with haemophilia were infected with HIV after treatment with blood-clotting drug Factor VIII Pharmaceutical giants...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 10 hours agoHemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO ...Proactive's Stephen Gunnion that 2023 was...
Pioneer Institute study finds IRA discourages non-opioid drug innovation
Pharmaceutical Technology via Yahoo Finance· 10 hours agoMovement in the non-opioid pain drug space Still, some updates continue to happen in the the pain...
Biodexa secures rights to eRapa for FAP treatment By Investing.com
Investing.com· 13 hours agoBiodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company, announced...
